|
1
|
Kliment CR, Englert JM, Gochuico BR, et
al: Oxidative stress alters syndecan-1 distribution in lungs with
pulmonary fibrosis. J Biol Chem. 284:3537–3545. 2009. View Article : Google Scholar :
|
|
2
|
Selman M and Pardo A: The
epithelial/fibroblastic pathway in the pathogenesis of idiopathic
pulmonary fibrosis. Am J Resp Cell Mol Bio. 29:S93–S97. 2003.
|
|
3
|
Ramos C, Becerril C, Montaño M, et al:
FGF-1 reverts epithelial-mesenchymal transition induced by
TGF-{beta}1 through MAPK/ERK kinase pathway. Am J Physiol Lung Cell
Mol Physiol. 299:L222–L231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Willis BC, Liebler JM, Luby-Phelps K, et
al: Induction of epithelial-mesenchymal transition in alveolar
epithelial cells by transforming growth factor-β1: potential role
in idiopathic pulmonary fibrosis. Am J Pathol. 166:1321–1332. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim KK, Kugler MC, Wolters PJ, et al:
Alveolar epithelial cell mesenchymal transition develops in vivo
during pulmonary fibrosis and is regulated by the extracellular
matrix. Proc Natl Acad Sci USA. 103:13180–13185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Willis BC and Borok Z: TGF-beta-induced
EMT: mechanisms and implications for fibrotic lung disease. AM J
Physiol Lung Cell Mol Physiol. 293:L525–L534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tanjore H, Xu XC, Polosukhin VV, et al:
Contribution of epithelial-derived fibroblasts to bleomycin-induced
lung fibrosis. Am J Respir Crit Care Med. 180:657–665. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Selman M and Pardo A: Idiopathic pulmonary
fibrosis: misunderstandings between epithelial cells and
fibroblasts? Sarcoidosis Vasc Diffuse Lung Dis. 21:165–172.
2004.PubMed/NCBI
|
|
9
|
Acloque H, Adams MS, Fishwick K, et al:
Epithelial-mesenchymal transitions: the importance of changing cell
state in development and disease. J Clin Invest. 119:1438–1449.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zavadil J and Böttinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morali OG, Delmas V, Moore R, et al:
IGF-II induces rapid β-catenin relocation to the nucleus during
epithelium to mesenchyme transition. Oncogene. 20:4942–4950. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Strutz F, Zeisberg M, Ziyadeh FN, et al:
Role of basic fibroblast growth factor-2 in epithelial-mesenchymal
transformation. Kidney Int. 61:1714–1728. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kasai H, Allen JT, Mason RM, et al: TGF-β1
induces human alveolar epithelial to mesenchymal cell transition
(EMT). Respir Res. 6:562005. View Article : Google Scholar
|
|
16
|
Meuten T, Hickey A, Franklin K, et al:
WNT7B in fibroblastic foci of idiopathic pulmonary fibrosis. Respir
Res. 13:622012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo Y, Xiao L, Sun L and Liu F:
Wnt/beta-catenin signaling: a promising new target for fibrosis
diseases. Physiol Res. 61:337–346. 2012.PubMed/NCBI
|
|
18
|
Borok Z: Role for alpha3 integrin in EMT
and pulmonary fibrosis. J Clin Invest. 119:7–10. 2009.
|
|
19
|
Selman M and Pardo A: Role of epithelial
cells in idiopathic pulmonary fibrosis: from innocent targets to
serial killers. Proc Am Thorac Soc. 3:364–372. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lawson WE, Polosukhin VV, Stathopoulos GT,
et al: Increased and prolonged pulmonary fibrosis in surfactant
protein C-deficient mice following intratracheal bleomycin. Am J
Pathol. 167:1267–1277. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang D, Liang J, Campanella GS, et al:
Inhibition of pulmonary fibrosis in mice by CXCL10 requires
glycosaminoglycan binding and syndecan-4. J Clin Invest.
120:2049–2057. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang D, Liang J, Hodge J, et al:
Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J
Clin Invest. 114:291–299. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and β-catenin signalling: diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bao XL, Song H, Chen Z and Tang X: Wnt3a
promotes epithelial-mesenchymal transition, migration, and
proliferation of lens epithelial cells. Mol Vis. 18:1983–1990.
2012.PubMed/NCBI
|
|
25
|
Gauldie J, Bonniaud P, Sime P, et al:
TGF-beta, Smad3 and the process of progressive fibrosis. Biochem
Soc Trans. 35:661–664. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moeller A, Ask K, Warburton D, et al: The
bleomycin animal model: a useful tool to investigate treatment
options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol.
40:362–382. 2008. View Article : Google Scholar
|
|
27
|
Moore BB and Hogaboam CM: Murine models of
pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol.
294:L152–L160. 2008. View Article : Google Scholar
|
|
28
|
Lewis CC, Yang JY, Huang X, et al:
Disease-specific gene expression profiling in multiple models of
lung disease. Am J Respir Crit Care Med. 177:376–387. 2008.
View Article : Google Scholar
|
|
29
|
Levänen B, Wheelock AM, Eklund A, et al:
Increased pulmonary Wnt (wingless/integrated)-signaling in patients
with sarcoidosis. Respir Med. 105:282–291. 2011. View Article : Google Scholar
|
|
30
|
Biernacka A, Dobaczewski M and
Frangogiannis NG: TGF-β signaling in fibrosis. Growth Factors.
29:196–202. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carre AL, James AW, MacLeod L, et al:
Interaction of wingless protein (Wnt), transforming growth
factor-beta1, and hyaluronan production in fetal and postnatal
fibroblasts. Plast Reconstr Surg. 125:74–88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sato M: Upregulation of the
Wnt/beta-catenin pathway induced by transforming growth factor-beta
in hypertrophic scars and keloids. Acta Derm Venereol. 86:300–307.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheon SS, Nadesan P, Poon R and Alman BA:
Growth factors regulate beta-catenin-mediated TCF-dependent
transcriptional activation in fibroblasts during the proliferative
phase of wound healing. Exp Cell Res. 293:267–274. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Izumo T, Kondo M and Nagai A: Effects of a
leukotriene B4 receptor antagonist on bleomycin-induced pulmonary
fibrosis. Eur Respir J. 34:1444–1451. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Robb WB, Condron C, Moriarty M, et al:
Taurine attenuates radiation-induced lung fibrosis in C57/Bl6
fibrosis prone mice. Ir J Med Sci. 179:99–105. 2010. View Article : Google Scholar
|
|
36
|
Jiang C, Huang H, Liu J, et al: Fasudil, a
rho-kinase inhibitor, attenuates bleomycin-induced pulmonary
fibrosis in mice. Int J Mol Sci. 13:8293–8307. 2012. View Article : Google Scholar : PubMed/NCBI
|
